Skip to main content
BIODYNE CO., LTD. logo

BIODYNE CO., LTD. — Investor Relations & Filings

Ticker · 314930 ISIN · KR7314930009 KO Manufacturing
Open in API
Filings indexed 118 across all filing types
Latest filing 2021-10-28 Major Shareholding Noti…
Country KR South Korea
Listing KO 314930

About BIODYNE CO., LTD.

https://biodyne.co.za/

BIODYNE CO., LTD. is a developer and manufacturer of medical devices, reagents, and consumables specializing in cancer diagnosis solutions. The company's core offering is the PATHPLORER Liquid-Based Cytology (LBC) system, which includes fully automatic cell preparation instruments and associated diagnostic kits. A key differentiator is its patented 'Blowing Technology,' a unique method for cell preparation in LBC diagnostics, which the company pioneered. BIODYNE focuses on providing advanced solutions for cytopathology to improve the accuracy and efficiency of disease screening.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and contractual arrangements (such as repurchase agreements) of major shareholders. This falls under the category of Major Shareholding Notification (MRQ) as it tracks significant ownership thresholds and changes.
2021-10-28 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '임시주주총회결과' (Extraordinary General Meeting Results) and provides the outcome of specific agenda items (amendment of articles of incorporation and appointment of an auditor) voted on during the meeting held on 2021-10-25. This fits the definition of a Declaration of Voting Results.
2021-10-25 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of Extraordinary General Meeting' (주주총회소집공고) for the company 'Biodyne'. It includes the meeting date, location, agenda items (such as changing the articles of incorporation and appointing an auditor), and instructions for shareholder voting, including electronic voting. It also contains sections on board activities and business overviews, which are standard components of a proxy statement/notice of meeting package. This document is clearly intended to inform shareholders of an upcoming meeting and solicit their participation, fitting the definition of a Proxy Solicitation & Information Statement.
2021-10-08 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of an Extraordinary General Meeting (EGM) for the company 'Biodine', detailing the date, location, and agenda items (such as articles of incorporation changes and auditor appointment). This type of document is a standard proxy solicitation or notice of meeting sent to shareholders to inform them of upcoming voting matters, which falls under the Proxy Solicitation & Information Statement category.
2021-09-10 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure for an upcoming Extraordinary General Meeting (EGM). It does not contain the full proxy materials or the meeting presentation itself, but rather serves as a formal notice of the procedural steps for the meeting. Given it is a standard regulatory disclosure regarding corporate governance and meeting preparation, it fits best under the general regulatory filing category.
2021-09-10 Korean
반기보고서 (2021.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for the company 'Biodyne' (바이오다인) for the period 2021.01.01 to 2021.06.30. It contains detailed financial data, business operations, capital structure, and management information. As it is a comprehensive financial report for a period shorter than a full fiscal year (half-year) and contains substantive financial statements and analysis, it is classified as an Interim/Quarterly Report. H1 2021
2021-08-17 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.